Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Swiss pharmaceutical giant Novartis has reported that it will invest $700 million in a cell culture production facility in Singapore that will support clinical and commercial production of potential new products in biopharmaceutical therapies.
Subscribe to our email newsletter
The proposed new facility, expected to be operational by 2012, is expected to be Novartis’s biggest investment in its manufacturing capacity.
A $180 million plant that manufactures Novartis tablets has already become operational in Singapore.